Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioAtla (BCAB) Accumulated Expenses (2020 - 2025)

BioAtla's Accumulated Expenses history spans 6 years, with the latest figure at $37000.0 for Q4 2025.

  • For Q4 2025, Accumulated Expenses fell 98.64% year-over-year to $37000.0; the TTM value through Dec 2025 reached $37000.0, down 98.64%, while the annual FY2025 figure was $37000.0, 98.64% down from the prior year.
  • Accumulated Expenses reached $37000.0 in Q4 2025 per BCAB's latest filing, down from $2.4 million in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $3.8 million in Q4 2023 to a low of $37000.0 in Q4 2025.
  • Average Accumulated Expenses over 5 years is $2.1 million, with a median of $2.2 million recorded in 2021.
  • Peak YoY movement for Accumulated Expenses: grew 29.2% in 2022, then plummeted 98.64% in 2025.
  • A 5-year view of Accumulated Expenses shows it stood at $2.7 million in 2021, then rose by 29.2% to $3.5 million in 2022, then rose by 9.82% to $3.8 million in 2023, then fell by 28.07% to $2.7 million in 2024, then tumbled by 98.64% to $37000.0 in 2025.
  • Per Business Quant, the three most recent readings for BCAB's Accumulated Expenses are $37000.0 (Q4 2025), $2.4 million (Q3 2025), and $1.6 million (Q2 2025).